by
According to the Foreclaro Global Research, the
Global
Next-Generation Sequencing (NGS) Market size was valued at USD 8427.6
million in 2024. The report “Global
Next-Generation Sequencing (NGS) Market Segmentation By
Technology (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted
Sequencing {Gene Panels, Custom Targeted Sequencing}, RNA Sequencing {Transcriptome
Sequencing, Single-Cell RNA Sequencing}, Epigenetics Sequencing {ChIP-Seq
(Chromatin Immunoprecipitation Sequencing), Methylation Sequencing}, Metagenomics
Sequencing), By Product Type (Sequencing Platforms, Consumables & Reagents
{Sequencing Kits, Sample Preparation Kits, Libraries}, Software & Services),By
Application (Oncology {Cancer Genome Sequencing, Liquid Biopsy, Biomarker
Discovery}, Reproductive Health, Infectious Diseases, Agricultural & Animal
Research, Drug Discovery & Development, Forensics), By End User (Academic
& Research Institutes, Hospitals & Clinics, Pharmaceutical &
Biotechnology Companies, Diagnostic Laboratories, Government Agencies)- Industry Trends and Forecast to
2033” gives a
detailed insight into current market dynamics and provides analysis on future
market growth.
The Next-Generation Sequencing (NGS) market is
hastily reworking healthcare, lifestyles sciences, and biotechnology via
allowing high-throughput, cost-effective, and accurate genetic analysis. NGS
generation allow whole sequencing of genomes, exomes, and transcriptomes,
offering crucial insights into oncology, infectious diseases, reproductive
health, precision medication, and agricultural studies. The marketplace is
pushed through improvements in sequencing platforms, declining fees in step
with genome, and the developing customized medication and biomarker discovery.
Key programs consist of most cancers diagnostics, liquid biopsy, uncommon
disorder identification, and microbial genomics. Pharmaceutical and
biotechnology organizations leverage NGS for drug discovery and development, at
the same time as hospitals, diagnostic labs, and educational studies
establishments more and more combine NGS into medical and translational
studies. Emerging developments consisting of single-molecular sequencing,
epigenomics, and metagenomics are similarly increasing the scope of programs.
With robust adoption in North America and Europe and speedy enlargement in
Asia-Pacific, the NGS marketplace is poised for considerable increase and
broader accessibility worldwide.
Have any questions or need more information?
Click the link below to request a sample or make an inquiry before making your
purchase:
https://foreclaroglobalresearch.com/research-report/global-next-generation-sequencing-ngs-market
Global Next-Generation
Sequencing (NGS) Market Report Highlights
· Rising
adoption of precision medicine, most cancers diagnostics, and infectious
ailment trying out are fueling international NGS demand.
· Continuous
improvements in sequencing platforms, single-mobileular sequencing, and
epigenomics are improving performance and accuracy.
· Declining
value in keeping with genome and advanced bioinformatics gear are making NGS
greater handy throughout scientific and studies applications.
· Oncology,
reproductive health, drug discovery, agricultural genomics, and microbiome
research constitute key boom areas.
· North
America leads due to strong healthcare infrastructure and R&D, even as
Asia-Pacific shows the fastest growth driven thru growing genomic initiatives.
· Strategic
partnerships, acquisitions, and product launches thru essential game
enthusiasts like Illumina, Thermo Fisher Scientific, and BGI are reshaping
market competition.
Foreclaro
Global Research has segmented the Next-Generation Sequencing (NGS) Market
report based on Technology, Product Type, Application, End User, and region:
Next-Generation
Sequencing (NGS) Market, Technology Outlook (Revenue - USD Million, 2020 -
2033)
Whole
Genome Sequencing (WGS)
Whole Exome
Sequencing (WES)
Targeted
Sequencing
·
Gene
Panels
·
Custom
Targeted Sequencing
RNA
Sequencing
·
Transcriptome
Sequencing
·
Single-Cell
RNA Sequencing
Epigenetics
Sequencing
·
ChIP-Seq
(Chromatin Immunoprecipitation Sequencing)
·
Methylation
Sequencing
Metagenomics
Sequencing
Next-Generation
Sequencing (NGS) Market, Product Type Outlook (Revenue - USD Million, 2020 -
2033)
Sequencing
Platforms
Consumables
& Reagents
·
Sequencing
Kits
·
Sample
Preparation Kits
·
Libraries
Software
& Services
Next-Generation
Sequencing (NGS) Market, Components Outlook (Revenue - USD Million, 2020 -
2033)
Oncology
·
Cancer
Genome Sequencing
·
Liquid
Biopsy
·
Biomarker
Discovery
Reproductive
Health
Infectious
Diseases
Agricultural
& Animal Research
Drug
Discovery & Development, Forensics
Next-Generation
Sequencing (NGS) Market, End User Outlook (Revenue - USD Million, 2020 - 2033)
Academic
& Research Institutes
Hospitals
& Clinics
Pharmaceutical
& Biotechnology Companies
Diagnostic
Laboratories
Government
Agencies
Next-Generation
Sequencing (NGS) Market, Site of Delivery Outlook (Revenue - USD Million, 2020
- 2033)
Banking
& Financial Services
Government
& Defense
Healthcare
Telecom
& IT
Transport
& Logistics
Retail
& Hospitality
Other
Next-Generation
Sequencing (NGS) Market, Regional Outlook (Revenue - USD Million, 2020 - 2033)
North
America
·
United
States
·
Canada
·
Mexico
Europe
·
United
Kingdom
·
Germany
·
France
·
Spain
·
Italy
·
Rest
of Europe
Asia
Pacific
·
China
·
India
·
Japan
·
Australia
·
South
Korea
·
Rest
of Asia Pacific
Latin
America
·
Brazil
·
Argentina
·
Rest
of Latin America
Middle East
& Africa
·
Saudi
Arabia
·
South
Africa
·
Rest
of MEA
Global Next-Generation Sequencing (NGS) Market Key
Players
·
Illumina
·
F. Hoffman-La Roche Ltd.
·
QIAGEN
·
Thermo Fisher Scientific, Inc.
·
Bio-Rad Laboratories, Inc.
·
Oxford Nanopore Technologies
·
PierianDx
·
Genomatix GmbH
·
DNASTAR, Inc.
·
Perkin Elmer, Inc.
·
Eurofins GATC Biotech GmbH
·
BGI
